SARCOMA
Clinical trials for SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SARCOMA trials appear
Sign up with your email to follow new studies for SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer therapy targets tough tumors with radioactive precision
Disease control TerminatedThis early-stage trial tested a two-step radioimmunotherapy combining GD2-SADA and 177Lu-DOTA in patients with recurrent or metastatic solid tumors, including small cell lung cancer, high-risk neuroblastoma, sarcoma, and melanoma. The goal was to assess safety and find the right …
Matched conditions: SARCOMA
Phase: PHASE1 • Sponsor: Y-mAbs Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug tested for rare cancer, trial stopped early
Disease control TerminatedThis study tested a drug called XmAb23104 in people with advanced sarcoma, a rare cancer. The goal was to see if the drug could shrink tumors and if it was safe. Only 6 people took part before the study was ended early.
Matched conditions: SARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New cancer drug OC-001 tested in advanced tumors – trial ends early
Disease control TerminatedThis early-phase trial tested an experimental drug called OC-001, given alone or with the immunotherapy avelumab, in 73 people with various advanced or metastatic cancers (like lung, breast, and bladder cancer). The main goals were to check safety and how the drug moves through t…
Matched conditions: SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Registry launched to understand young adult cancer Survivors' wellbeing
Knowledge-focused TerminatedThis observational registry aims to learn about the health, wellbeing, and needs of people who were diagnosed with cancer between ages 18 and 39. Participants complete surveys every 6 to 12 months about anxiety, depression, social support, and financial distress. The registry als…
Matched conditions: SARCOMA
Sponsor: Young Adult Survivors United • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Can a heart scan predict chemo danger?
Knowledge-focused TerminatedThis study aimed to find early markers of heart damage from chemotherapy in people with sarcoma. Researchers used advanced heart imaging (2D and 3D echocardiography) to track changes in heart function over time. The goal was to identify patients at highest risk for heart failure …
Matched conditions: SARCOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC